Clinical Trials
16 trialsNCT06502691 2026-05-19
[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer
University of Washington
Phase 1/2 Recruiting
NCT01042379 2026-05-06
I-SPY
QuantumLeap Healthcare Collaborative
Phase 2 Recruiting
NCT06608446 2026-04-21
LINFO
Fondazione Policlinico Universitario Campus Bio-Medico
Phase NA Recruiting
NCT05787834 2026-03-18
Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer
Roswell Park Cancer Institute
Phase NA Recruiting
NCT06422455 2026-03-18
Access to Genetic Testing in Underserved Patients With Cancer
University of Southern California
Phase NA Recruiting
NCT07464457 2026-03-11
NEOPRO-SIT
University Hospital Muenster
Phase NA Recruiting
NCT03808337 2026-02-27
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT04751435 2025-10-21
IMAGINE
Memorial Sloan Kettering Cancer Center
Phase NA Recruiting
NCT04567420 2025-10-16
DARE
Criterium, Inc.
Phase 2 Recruiting
NCT05754658 2025-10-06
African Cancer Genome: GMD
Fox Chase Cancer Center
Recruiting
NCT06813053 2025-08-12
A Novel Patient Decision Aid for Surgical Treatment Options in Early-Stage Breast Cancer
University of Colorado, Denver
Phase NA Recruiting
NCT06989450 2025-05-25
Digital Patient Support Program for Self-efficacy and Medication Adherence in Women on Adjuvant Endocrine Treatment for Breast Cancer
Sidekick Health
Phase NA Recruiting
NCT06309290 2025-04-02
NEO STRONG
Universidad de La Frontera
Phase NA Recruiting
NCT06726889 2024-12-20
Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients
European Institute of Oncology
Recruiting
NCT06144346 2023-11-22
Metastases Directed Therapy for Oligometastatic Breast Cancer
National Cancer Institute, Egypt
Phase NA Recruiting
NCT05263570 2022-09-13
The Efficiency for Stage II-III HR+/HER2+ Early Breast Cancer Patient With Standard Neoadjuvant Therapy in Real World.
Shengjing Hospital
Recruiting